Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Savarese

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Obstetrics and Gynecology|October 1, 1996
Ovarian Burkitt lymphoma: pelvic pain in a woman with AIDSB Neary, S B Young, K L Reuter, et al.
Seminars in Oncology|December 22, 1999
A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: preliminary results of cancer and leukemia group B Trial 9780D Savarese, M E Taplin, S Halabi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: a feasibility studyA B Kornblith, J E Herndon, E Zuckerman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 5, 2001
Paclitaxel and concurrent radiation for locally advanced pancreatic cancerH Safran, T Moore, D Iannitti, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Obstetrics and Gynecology|October 1, 1996
Ovarian Burkitt lymphoma: pelvic pain in a woman with AIDSB Neary, S B Young, K L Reuter, et al.
Seminars in Oncology|December 22, 1999
A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: preliminary results of cancer and leukemia group B Trial 9780D Savarese, M E Taplin, S Halabi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: a feasibility studyA B Kornblith, J E Herndon, E Zuckerman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 5, 2001
Paclitaxel and concurrent radiation for locally advanced pancreatic cancerH Safran, T Moore, D Iannitti, et al.
Pageof 1